Neoadjuvant chemoimmunotherapy confers survival advantage for patients undergoing sleeve lobectomy.

Tao ChenJialiang WenYiming HeYifan ZhongJiajun DengQiankun ChenYunlang SheLei JiangDong XieDeping ZhaoChang Chen

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)

Neoadjuvant ICI plus chemotherapy was correlated with favourable long-term survival in patients with non-small cell lung cancer undergoing sleeve lobectomy.

Keyphrases

locally advanced
rectal cancer
patients undergoing
lymph node
squamous cell carcinoma
radiation therapy
thoracic surgery
free survival